Research Presented at the 2013 Breast Cancer Symposium
The 2013 Breast Cancer Symposium was held September 7 - 9, 2013, in San Francisco, California. The Symposium was cosponsored by the American Society of Breast Disease, the American Society of Breast Surgeons, the American Society of Clinical Oncology, the American Society for Radiation Oncology, the National Consortium of Breast Centers, and the Society of Surgical Oncology.
Reclaiming Sexuality in the Face of Breast Cancer
by Michael Krychman, MD, Alyssa Dweck, MS, MD, FACOG, and Susan Kellogg Spadt, PhD, CRNP
Sexual issues are common in breast cancer survivors. Treatment, including surgery, radiation, and chemotherapy, coupled with hormonal medications and the emotional impact of the diagnosis can affect a woman’s sexual response cycle and sexual satisfaction.
FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment
The U.S. Food and Drug Administration has granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.
After Breast Cancer
After completing treatment for breast cancer, follow-up care is important to help maintain good health, which includes managing any side effects from treatment and watching for long-term side effects (called late effects) or signs of a cancer recurrence.
What Do You Need to Know About Ovarian and Breast Cancer Risk?
In the wake of Angelina Jolie’s announcement that she carries a genetic mutation linked to breast and ovarian cancers, thousands of women are wondering whether they are at risk. To address their concerns, four women’s health organizations have joined together to provide essential information about risk factors and symptoms of ovarian cancer.
Sit Back, Relax, and Enjoy the Summer
Summer can be the best of times, or, if you’re in breast cancer treatment or recovery, the most challenging of times. It’s a season to enjoy the outdoors, go on vacation, and spend time with family and friends.
Becoming a Mother after Breast Cancer Treatment
by Evelyn Mok-Lin, MD, and Glenn Schattman, MD
The opportunity to have children, raise a family, and experience the joys of motherhood is a very real prospect for many young women with breast cancer. The American Cancer Society estimates that there are currently over 350,000 young women between the ages of 20 and 39 years old living with cancer in the U.S. Because there are so many reproductive-age cancer survivors who may want children in the future, the topic of fertility has become increasingly important to a woman’s treatment, recovery, and healing process.
Young Women & Breast Cancer
Once you have completed treatment for breast cancer, you may have some lingering side effects. Where you once felt like a healthy young woman, you may now encounter what feels like constantly changing physical ailments. It is natural to become frustrated with these issues, but knowing what to look for and open communication with your medical team can help alleviate symptoms and worry.